Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Average Rating of “Moderate Buy” from Analysts

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has received a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the company, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year price objective among analysts that have covered the stock in the last year is $22.40.

A number of brokerages recently weighed in on SBRA. Weiss Ratings cut shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research report on Thursday, June 4th. Scotiabank raised their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “sector perform” rating in a research report on Thursday, May 21st. Citizens Jmp boosted their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “market outperform” rating in a research note on Wednesday, February 18th. Citigroup upped their target price on Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, February 18th. Finally, UBS Group increased their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Wednesday, May 13th.

Institutional Trading of Sabra Healthcare REIT

A number of hedge funds have recently made changes to their positions in SBRA. Principal Financial Group Inc. grew its stake in shares of Sabra Healthcare REIT by 21.6% during the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock valued at $472,617,000 after acquiring an additional 4,431,897 shares in the last quarter. Lasalle Investment Management Securities LLC purchased a new stake in shares of Sabra Healthcare REIT during the fourth quarter worth about $66,938,000. Norges Bank acquired a new position in shares of Sabra Healthcare REIT in the fourth quarter worth about $57,945,000. Sumitomo Mitsui Trust Group Inc. lifted its stake in shares of Sabra Healthcare REIT by 1,019.8% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,005,374 shares of the real estate investment trust’s stock worth $56,922,000 after acquiring an additional 2,736,993 shares in the last quarter. Finally, Balyasny Asset Management L.P. purchased a new position in Sabra Healthcare REIT in the second quarter valued at about $49,955,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Down 0.1%

Shares of SBRA stock opened at $18.56 on Wednesday. The stock has a market cap of $4.68 billion, a price-to-earnings ratio of 29.46, a price-to-earnings-growth ratio of 1.38 and a beta of 0.64. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96. Sabra Healthcare REIT has a fifty-two week low of $17.17 and a fifty-two week high of $21.28. The firm’s 50 day moving average price is $20.01 and its two-hundred day moving average price is $19.68.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company had revenue of $211.74 million during the quarter, compared to analyst estimates of $209.20 million. During the same quarter in the prior year, the business earned $0.37 earnings per share. The business’s quarterly revenue was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, analysts anticipate that Sabra Healthcare REIT will post 1.51 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.5%. The ex-dividend date was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio is currently 190.48%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.